🇦🇺 Australia TGA

CJC-1295

Long-acting GHRH analogue that stimulates sustained growth hormone release

Research only available TGA
Key stats Research
6-8 days
Half-life (DAC formulation)
GHRH
Mechanism class
Pituitary
Primary site of action
Phase 1/2
Human trial data available
🇦🇺 Australia TGA

🇦🇺 Australia · TGA

Legal status

🇦🇺 Australia — TGA
available

CJC-1295 is not approved for therapeutic use in Australia. Not a controlled substance. Legal to purchase for research purposes under TGA guidelines. Verify current status before ordering.

This website is intended for research and educational purposes only. The information provided does not constitute medical advice and should not be used to diagnose, treat, cure, or prevent any condition. Peptides discussed on this site are not approved by the TGA for human therapeutic use. Always consult a qualified healthcare professional before using any substance.

Full legal guide for Australia →

Frequently asked

Common questions

Is CJC-1295 legal in Australia?

CJC-1295 is not approved for therapeutic use in Australia and is not a controlled substance. It can be purchased for legitimate research purposes under TGA guidelines.

Can I buy CJC-1295 in Australia?

Research-grade CJC-1295 is available from vendors that ship to Australia. It is not available from pharmacies as it has not received TGA therapeutic approval.

Where to source CJC-1295

CJC-1295 in Australia

We verify COA documentation and purity standards before listing any vendor.

Get vendor access →